Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Core Laboratories N.V.

In a report released today, from J.P. Morgan assigned a Buy rating to Cellebrite DI, with a price target of $16.00. In a report released today, Nee...

J.P. Morgan Gives a Buy Rating to Cellebrite DI (CLBT)

Cellebrite DI ( ($CLBT) ) has issued an announcement. Effective August 13, 2026, Cellebrite DI Ltd. executed a planned leadership succession in whi...

Cellebrite Announces CEO Transition to Shiven Ramji in Planned Succession

Cellebrite DI ( ($CLBT) ) has issued an update. Cellebrite DI Ltd., a digital intelligence solutions provider for law enforcement and government cu...

Cellebrite DI Files Stronger First-Half 2026 Results With Rising Subscription Revenue

Stifel Nicolaus analyst Daryl Young maintained a Buy rating on CCL Industries today and set a price target of C$105.00. According to TipRanks, Youn...

CCL Industries (CCDBF) Receives a Buy from Stifel Nicolaus

An update from Cellebrite DI ( ($CLBT) ) is now available. On August 13, 2026, Cellebrite announced a planned leadership transition in which Shiven...

Cellebrite Names New CEO as Q2 2026 Growth Slows and Outlook Is Reset

Celebrus Technologies ( ($GB:CLBS) ) has shared an announcement. Celebrus Technologies plc has executed a share buyback, purchasing 25,000 ordinary...

Celebrus Technologies Updates Share Capital After Treasury Share Buyback

D.A. Davidson analyst Rudy Kessinger maintained a Buy rating on Cellebrite DI today and set a price target of $22.00. According to TipRanks, Kessin...

D.A. Davidson Keeps Their Buy Rating on Cellebrite DI (CLBT)

Celebrus Technologies ( ($GB:CLBS) ) just unveiled an announcement. Celebrus Technologies plc has executed a share buyback transaction, purchasing ...

Celebrus Technologies Updates Voting Rights After Share Buyback

The latest announcement is out from Celebrus Technologies ( ($GB:CLBS) ). Celebrus Technologies plc disclosed that it has repurchased 18,713 of its...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLB	$12.45	0.00%	741.35K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CLB	$12.45	0%	741.35K
3
4
5
6

CLB

Get Core Laboratories N.V. Data in Excel

Get Core Laboratories N.V. Data in Excel